OBR Daily Commentary

forumImage

Top Oncologists Push Back on ‘Outrageous’ Costs of Cancer Drugs’

(KHN Morning Briefing) July 23, 2015 - More than 110 doctors from cancer centers around the country called on drug makers to justify their soaring prices and for the government to put regulatory curbs in place. They noted that every new drug approved by the Food and Drug Administration in 2014 was priced at more than $120,000 per year.

Read Article arrow

Dean Gesme, MD (Posted: July 23, 2015)

quotesThe entire oncology community agrees that pricing of new drugs has become unsustainable. Thank you to all of those involved in seeking remedies to this systemic socioeconomic illness.quotes

Add Comment 1 Comment
forumImage

CVS Health Leaving U.S. Chamber Of Commerce Over Smoking Spat

(Fortune) July 8, 2015 - The pharmacy is quitting the Chamber over the trade group’s efforts to target anti-smoking laws abroad, saying it runs counter to its efforts to promote better health.

Read Article arrow

Dean Gesme, MD (Posted: July 08, 2015)

quotesHats off to CVS for taking a stand against international tobacco promotional efforts!quotes

Add Comment 1 Comment
forumImage

Why Gene-Editing Technology Has Scientists Excited

(Wall Street Journal) June 28, 2015 - A new technology for “editing” defective genes has raised hopes for a future generation of medicines treating intractable diseases like cancer, cystic fibrosis and sickle-cell anemia.

Read Article arrow

Dean Gesme, MD (Posted: June 29, 2015)

quotesCRISPR is a phrase that we all need to watch carefully as it probably represents the most promising biologic technique in recent years. It takes a DNA identification and splicing technique used by bacteriophages and adapts it to accomplish selective gene splicing in multicellular organisms. A multitude of scientific discoveries will certainly result which will dramatically effect the treatment of cancer and many other diseases.quotes

Add Comment 1 Comment

Meet the Editorial Board

Community Oncology
member photo
Dean Gesme, MD

FACP FACPE FASCO President, Minnesota Oncology...

Breast Cancer
member photo
Debu Tripathy, MD

Professor and Chair, Department of Breast Medical Oncol...

Lung Cancer
member photo
H. Jack West, MD

Medical Director, Thoracic Oncology Program, Swedish Ca...

Gastrointestinal Cancers
member photo
Howard S. Hochster, MD

Associate Cancer Center Director, Yale Cancer Center P...

Community Oncology
member photo
Jeff Patton, M.D.

CEO Tennessee Oncology...

Precision Medicine Section Editor
member photo
Jennifer Levin Carter, MD, MPH

Chief Medical Officer and Founder, N-of-One...

Financial Sector
member photo
Michael G. King Jr.

Managing Director and Senior Biotechnology Analyst...

Gastrointestinal Cancers
member photo
Richard Goldberg, MD

Director WVU Cancer Institute Director of Cancer Signa...

Editor-In-Chief
member photo
Robert A. Figlin, MD., FACP

Professor and Director, Division of Hematology Oncology...

Health Policy
member photo
Ted Okon

Executive Director Community Oncology Alliance...

Community Oncology
member photo
Thomas Marsland, MD

Vice President Integrated Community Oncology Network ...

Community Oncology
member photo
William Harwin MD

Florida Cancer Specialists President and Managing Part...

Health Policy
member photo
William McGivney, PhD

National Health Policy Expert...

Payer
member photo
Winston Wong, PharmD

President, W-Squared Group...